Lenacapavir works to both treat and prevent HIV, making it a promising drug should it be approved by the FDA later this month.

By bolstering immune cells, researchers at ViiV Healthcare in Branford have designed long-acting drugs that prevent infection ...

Updated CDC guidelines on PEP after nonoccupational HIV exposure address newer ART agents and clinical considerations for patients with a history of long-acting ART.

The impact of US President Donald Trump administration’s slashing of over half of South Africa’s HIV and TB projects, ...

The S&P 500 index closed higher on Monday as investors were still optimistic over trade talks between the United States and ...